Useful information

10.08.2016 Medicine safety and results of pharmacovigilance

20.08.2014 Simply about adverse drug reactions

The publication explains why any medicinal products can cause adverse reactions and how the benefit-risk balance determines whether their use is appropriate. Intended for healthcare professionals, pharmacists, and patients seeking information on medicine safety and the rules for using package leaflets. generated automatically

20.08.2014 Recommended list of literature sources for the applicant’s monitoring of medicinal product safety information (by trade name, by INN)

Recommended list of literature sources that the applicant should monitor to track safety information on medicinal products by trade name and INN. Contains an annex with scientific collections, journals, and publications, as well as recommendations on monitoring legal acts and official websites of regulatory authorities. compiled automatically

1.06.2014 Following the participation of V. Yaichenia, an employee of the post-registration surveillance department, in the training seminar “Surveillance and monitoring of substandard/spurious/falsely labelled/falsified/counterfeit medicinal products (Substandard/Spurious/Falselylabelled/Falsified/Counterfeit (SSFFC)

The material covers the participation of a specialist of the post-registration surveillance department in a WHO training workshop on the surveillance and monitoring of substandard, spurious, falsified medicinal products. It describes the purpose of the event, the global system for collecting data on such cases, and examples of international coordination. generated automatically

03.03.2014 Health through vaccination

An article by specialists of the State Expert Center of the Ministry of Health of Ukraine, devoted to reviewing a publication on the alleged danger of vaccines and substantiating the expediency and benefits of immunoprophylaxis. Intended for healthcare workers and aimed at fostering an objective attitude toward vaccination. compiled automatically

03.03.2014 Comments on the article “Vaccines Are Killing Again” published in the newspaper Vashe Zdorovya No. 07-08 of 21.02.2014

Official position of the State Expert Center of the Ministry of Health of Ukraine on a publication in the newspaper “Vashe Zdorovia” that contained an arbitrary interpretation of data on the temporary suspension of vaccine batches. The document explains why inaccurate coverage of information on medicinal products is unacceptable and emphasizes the importance of immunoprophylaxis. compiled automatically

18.11.2013 Information on the results of participation in the technical meeting of representatives of countries with experience in pharmacovigilance of the toxicity of antiretroviral medicinal products, 7-8 November 2013, Geneva, Switzerland

The material covers the outcomes of the WHO technical meeting (Geneva, 7–8 November 2013) on pharmacovigilance of the toxicity of antiretroviral drugs. It describes new WHO recommendations on HIV treatment and prevention, key issues of ART toxicity and approaches to monitoring adverse reactions. generated automatically

14.08.2013 “MoH of Ukraine press release on the treatment of children with cystic fibrosis with pancreatin-containing medicinal products”

MoH of Ukraine press release on the use of pancreatin-containing products in children with cystic fibrosis: describes appeals from patients and doctors, pharmacovigilance results, the temporary ban of a batch of one of the products, and the working group's conclusions on their interchangeability. generated automatically

24.05.2013 Report of the experts of the Pharmaceutical Systems Strengthening Program of the Center for Pharmaceutical Management, Management Sciences for Health (MSH). July 2012

The report is devoted to assessing the pharmacovigilance system in Ukraine and its effectiveness, in particular issues of medicinal product safety and post-registration surveillance. Prepared for specialists in the field of medicinal product circulation, regulatory authorities and organizations involved in ensuring the safety of medicines. generated automatically

21.05.2013 Quality of medical care adverse reactions to medicinal products

The article is devoted to the analysis of fatal outcomes of adverse reactions to medicinal products according to pharmacovigilance data in Ukraine in 2012. Cases of patient deaths for which a causal relationship with the use of medicines was established are examined, and the relevant clinical data are presented. generated automatically